• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外泌体模拟纳米囊泡与外泌体的蛋白质组学和翻译后修饰谱分析比较。

Proteomic and Post-Translational Modification Profiling of Exosome-Mimetic Nanovesicles Compared to Exosomes.

机构信息

Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Victoria, 3086, Australia.

Department of Health Science and Technology, Faculty of Medicine, Aalborg University, Aalborg, 9220, Denmark.

出版信息

Proteomics. 2019 Apr;19(8):e1800161. doi: 10.1002/pmic.201800161. Epub 2019 Apr 3.

DOI:10.1002/pmic.201800161
PMID:30790448
Abstract

Issues associated with upscaling exosome production for therapeutic use may be overcome through utilizing artificial exosomes. Cell-derived mimetic nanovesicles (M-NVs) are a potentially promising alternative to exosomes for clinical applicability, demonstrating higher yield without incumbent production and isolation issues. Although several studies have shown that M-NVs have similar morphology, size and therapeutic potential compared to exosomes, comprehensive characterization and to what extent M-NVs components mimic exosomes remain elusive. M-NVs were generated through the extrusion of cells and proteomic profiling demonstrated an enrichment of proteins associated with membrane and cytosolic components. The proteomic data herein reveal a subset of proteins that are highly abundant in M-NVs in comparison to exosomes. M-NVs contain proteins that largely represent the parental cell proteome, whereas the profile of exosomal proteins highlight their endosomally derived origin. This advantage of M-NVs alleviates the necessity of endosomal sorting of endogenous therapeutic proteins or RNA into exosomes. This study also highlights differences in protein post-translational modifications among M-NVs, as distinct from exosomes. Overall this study provides key insights into defining the proteome composition of M-NVs as a distinct from exosomes, and the potential advantage of M-NVs as an alternative nanocarrier when spontaneous endosomal sorting of therapeutics are limited.

摘要

用于治疗用途的外泌体生产放大相关问题可以通过利用人工外泌体来克服。细胞衍生的模拟纳米囊泡(M-NVs)是外泌体在临床应用中具有潜在应用前景的替代品,其产量更高,不存在当前生产和分离的问题。尽管几项研究表明 M-NVs 在形态、大小和治疗潜力方面与外泌体相似,但对 M-NVs 成分与外泌体的模拟程度的全面表征仍然难以捉摸。M-NVs 通过细胞挤压产生,蛋白质组学分析表明,M-NVs 中富含与膜和细胞质成分相关的蛋白质。本文中的蛋白质组学数据揭示了与外泌体相比,M-NVs 中高度丰富的蛋白质子集。M-NVs 包含的蛋白质在很大程度上代表了亲本细胞的蛋白质组,而外泌体蛋白的特征则突出了它们的内体起源。M-NVs 的这一优势减轻了将内源性治疗蛋白或 RNA 内体分拣到外泌体中的必要性。本研究还强调了 M-NVs 中蛋白质翻译后修饰的差异,与外泌体不同。总的来说,这项研究为定义 M-NVs 的蛋白质组组成提供了重要的见解,M-NVs 作为一种替代纳米载体具有潜在的优势,特别是在治疗药物的内体分拣受到限制时。

相似文献

1
Proteomic and Post-Translational Modification Profiling of Exosome-Mimetic Nanovesicles Compared to Exosomes.外泌体模拟纳米囊泡与外泌体的蛋白质组学和翻译后修饰谱分析比较。
Proteomics. 2019 Apr;19(8):e1800161. doi: 10.1002/pmic.201800161. Epub 2019 Apr 3.
2
Attenuation of Tumor Necrosis Factor-α Induced Inflammation by Umbilical Cord-Mesenchymal Stem Cell Derived Exosome-Mimetic Nanovesicles in Endothelial Cells.脐带间充质干细胞来源的外泌体模拟纳米囊泡减轻血管内皮细胞中肿瘤坏死因子-α诱导的炎症。
Tissue Eng Regen Med. 2020 Apr;17(2):155-163. doi: 10.1007/s13770-019-00234-7. Epub 2020 Feb 5.
3
Exosome-Mimetic Nanovesicles from Hepatocytes promote hepatocyte proliferation in vitro and liver regeneration in vivo.肝细胞来源的外泌体模拟纳米囊泡促进体外肝细胞增殖和体内肝再生。
Sci Rep. 2018 Feb 6;8(1):2471. doi: 10.1038/s41598-018-20505-y.
4
Mesenchymal stromal cell-derived nanovesicles ameliorate bacterial outer membrane vesicle-induced sepsis via IL-10.间质基质细胞衍生的纳米囊泡通过白细胞介素-10 改善细菌外膜囊泡诱导的脓毒症。
Stem Cell Res Ther. 2019 Aug 1;10(1):231. doi: 10.1186/s13287-019-1352-4.
5
A method for the isolation and enrichment of purified bovine milk exosomes.一种分离和富集纯化牛乳外泌体的方法。
Reprod Biol. 2017 Dec;17(4):341-348. doi: 10.1016/j.repbio.2017.09.007. Epub 2017 Oct 10.
6
Targeted Delivery of Mesenchymal Stem Cell-Derived Nanovesicles for Spinal Cord Injury Treatment.靶向递送间充质干细胞衍生的纳米囊泡治疗脊髓损伤。
Int J Mol Sci. 2020 Jun 11;21(11):4185. doi: 10.3390/ijms21114185.
7
Preparation of urinary exosomes: methodological issues for clinical proteomics.尿液外泌体的制备:临床蛋白质组学的方法学问题
Methods Mol Biol. 2015;1243:43-53. doi: 10.1007/978-1-4939-1872-0_3.
8
An Adaptable Polyethylene Glycol-Based Workflow for Proteomic Analysis of Extracellular Vesicles.一种适用于细胞外囊泡蛋白质组学分析的基于聚乙二醇的工作流程。
Methods Mol Biol. 2017;1660:303-317. doi: 10.1007/978-1-4939-7253-1_25.
9
An improvised one-step sucrose cushion ultracentrifugation method for exosome isolation from culture supernatants of mesenchymal stem cells.一种改良的一步蔗糖垫超速离心法,用于从间充质干细胞培养上清液中分离外泌体。
Stem Cell Res Ther. 2018 Jul 4;9(1):180. doi: 10.1186/s13287-018-0923-0.
10
Stem Cell-Engineered Nanovesicles Exert Proangiogenic and Neuroprotective Effects.干细胞工程化纳米囊泡发挥促血管生成和神经保护作用。
Materials (Basel). 2021 Feb 25;14(5):1078. doi: 10.3390/ma14051078.

引用本文的文献

1
Biological and Bioinspired Vesicles for Wound Healing: Insights, Advances and Challenges.用于伤口愈合的生物及仿生囊泡:见解、进展与挑战
Int J Nanomedicine. 2025 Jun 30;20:8497-8528. doi: 10.2147/IJN.S522067. eCollection 2025.
2
The biology of exosomes and exosomal non-coding RNAs in cardiovascular diseases.外泌体及外泌体非编码RNA在心血管疾病中的生物学特性
Front Pharmacol. 2025 May 26;16:1529375. doi: 10.3389/fphar.2025.1529375. eCollection 2025.
3
Artificial Cell-Derived Vesicles: Extracellular Vesicle Mimetics for Chondrocyte Restoration in TMJOA Therapy.
人工细胞衍生囊泡:颞下颌关节骨关节炎治疗中用于软骨细胞修复的细胞外囊泡模拟物
Int J Nanomedicine. 2025 Apr 26;20:5393-5405. doi: 10.2147/IJN.S508449. eCollection 2025.
4
Leveraging nature's nanocarriers: Translating insights from extracellular vesicles to biomimetic synthetic vesicles for biomedical applications.利用天然纳米载体:将细胞外囊泡的见解转化为用于生物医学应用的仿生合成囊泡。
Sci Adv. 2025 Feb 28;11(9):eads5249. doi: 10.1126/sciadv.ads5249. Epub 2025 Feb 26.
5
GMP-compliant manufacturing of biologically active cell-derived vesicles produced by extrusion technology.采用挤压技术符合药品生产质量管理规范(GMP)的生物活性细胞衍生囊泡的生产
J Extracell Biol. 2022 Dec 25;1(12):e70. doi: 10.1002/jex2.70. eCollection 2022 Dec.
6
Cutting-Edge HEK293T Protein-Integrated Lipid Nanostructures: Boosting Biocompatibility and Efficacy.尖端的 HEK293T 蛋白整合脂质纳米结构:提高生物相容性和疗效。
Int J Mol Sci. 2024 Mar 14;25(6):3294. doi: 10.3390/ijms25063294.
7
Unraveling the surface marker signature of cell-derived vesicles via proteome analysis and nanoparticle flow cytometry.通过蛋白质组分析和纳米颗粒流式细胞术揭示细胞衍生囊泡的表面标志物特征。
Sci Rep. 2024 Jan 2;14(1):121. doi: 10.1038/s41598-023-50279-x.
8
Engineered exosomes-based theranostic strategy for tumor metastasis and recurrence.基于工程化外泌体的肿瘤转移与复发诊疗策略
Asian J Pharm Sci. 2023 Nov;18(6):100870. doi: 10.1016/j.ajps.2023.100870. Epub 2023 Nov 29.
9
Mesenchymal stem cell-derived extracellular vesicles in skin wound healing: roles, opportunities and challenges.间质干细胞衍生的细胞外囊泡在皮肤伤口愈合中的作用、机遇和挑战。
Mil Med Res. 2023 Aug 17;10(1):36. doi: 10.1186/s40779-023-00472-w.
10
Cellular nanovesicles for therapeutic immunomodulation: A perspective on engineering strategies and new advances.用于治疗性免疫调节的细胞纳米囊泡:工程策略与新进展的展望
Acta Pharm Sin B. 2023 May;13(5):1789-1827. doi: 10.1016/j.apsb.2022.08.020. Epub 2022 Aug 28.